Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|July 17, 2025
Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordabilityJennifer G Gaultney, Daniel Ollendorf, Medha Sasane, et al.
Journal of Comparative Effectiveness Research|August 15, 2015
Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromesAmer M Zeidan, Franklin Hendrick, Erika Friedmann, et al.
Advances in Therapy|June 5, 2017
Monitoring for and Characterizing Crizotinib Progression: A Chart Review of ALK-Positive Non-Small Cell Lung Cancer PatientsEdmond Bendaly, Anand A Dalal, Kenneth Culver, et al.
Digestive Diseases and Sciences|August 20, 2002
Resource utilization associated with irritable bowel syndrome in the United States 1987-1997Ya-Chen Tina Shih, Victoria E Barghout, Robert S Sandler, et al.
Cancer Epidemiology|April 28, 2015
ALK rearrangement testing and treatment patterns for patients with ALK-positive non-small cell lung cancerAnnie Guérin, Medha Sasane, Jie Zhang, et al.
Current Medical Research and Opinion|December 16, 2014
Multicenter COMPACT study of COMplications in patients with sickle cell disease and utilization of iron chelation therapyLanetta Jordan, Patricia Adams-Graves, Julie Kanter-Washko, et al.
Pageof 5